Inovio Pharmaceuticals Inc vs Mongodb Inc — how do they compare? Inovio Pharmaceuticals Inc trades at $0.77 (market cap $78.55M), while Mongodb Inc trades at $432 (market cap $35.32B). The key difference: Mongodb Inc is far larger — about 449.6× Inovio Pharmaceuticals Inc's market cap, and Mongodb Inc is trading nearer its 52-week high, Inovio Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| INO | MDB | |
|---|---|---|
Market Cap | $78.55M | $35.32B |
Sector | Health | Technology |
52-Week High | $2.87 | $440.25 |
52-Week Low | $0.66 | $204.37 |
Enterprise Value | $49.56M | $32.93B |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →